Volumetric differences in the pituitary between drug-naïve and medicated male patients with obsessive-compulsive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 4, 2009, Pages 605-609

  Jung, Myung Hun ^a   Huh, Min Jung ^a   Kang, Do Hyung ^a   Choi, Jung Seok ^a   Jung, Wi Hoon ^b   Jang, Joon Hwan ^a   Park, Ji Young ^b   Han, Ji Yeon ^b   Choi, Chi Hoon ^c   Kwon, Jun Soo ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c National Medical Center   (South Korea)

Author keywords

Magnetic resonance imaging; Obsessive compulsive disorder; Pituitary gland

Indexed keywords

ADULT; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; HUMAN; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSESSIVE COMPULSIVE DISORDER; STRESS; VOLUMETRY;

ADOLESCENT; ANALYSIS OF VARIANCE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OBSESSIVE-COMPULSIVE DISORDER; PITUITARY GLAND; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 67349288079     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.02.017     Document Type: Article

References (54)

1. Altemus M., Pigott T., Kalogeras K.T., Demitrack M., Dubbert B., Murphy D.L., et al. Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry 49 (1992) 9-20
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (1994), American Psychiatric Press, Washington, DC
3. Axelson D.A., Doraiswamy P.M., Boyko O.B., Rodrigo Escalona P., McDonald W.M., Ritchie J.C., et al. In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Res 44 (1992) 63-70
4. Bailly D., Servant D., Dewailly D., Beuscart R., Racadot A., Fossati P., et al. Corticotropin releasing factor stimulation test in obsessive compulsive disorder. Biol Psychiatry 35 (1994) 143-146
5. Barden N., Reul J.M., and Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?. Trends Neurosci 18 (1995) 6-11
6. Catapano F., Monteleone P., Maj M., and Kemali D. Dexamethasone suppression test in patients with primary obsessive-compulsive disorder and in healthy controls. Neuropsychobiology 23 (1990) 53-56
7. Catapano F., Monteleone P., Fuschino A., Maj M., and Kemali D. Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder. Psychiatry Res 44 (1992) 217-225
8. Chappell P., Leckman J., Goodman W., Bissette G., Pauls D., Anderson G., et al. Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls. Biol Psychiatry 39 (1996) 776-783
9. Choi J.S., Kang D.H., Kim J.J., Ha T.H., Lee J.M., Youn T., et al. Left anterior subregion of orbitofrontal cortex volume reduction and impaired organizational strategies in obsessive-compulsive disorder. J Psychiatr Res 38 (2004) 193-199
10. Contesse V., Lefebvre H., Lenglet S., Kuhn J.M., Delarue C., and Vaudry H. Role of 5-HT in the regulation of the brain-pituitary-adrenal axis: effects of 5-HT on adrenocortical cells. Can J Physiol Pharm 78 (2000) 967-983
11. Cottraux J.A., Bouvard M., Claustrat B., and Juenet C. Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: a confirmatory report. Psychiatry Res 13 (1984) 157-165
12. Cromer K.R., Schmidt N.B., and Murphy D.L. An investigation of traumatic life events and obsessive-compulsive disorder. Behav Res Ther 45 (2007) 1683-1691
13. Dinc H., Esen F., Demirci A., Sari A., and Resit Gumele H. Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment. Acta Radiol 39 (1998) 64-69
14. Doraiswamy P.M., Krishnan K.R., Boyko O.B., Husain M.M., Figiel G.S., Palese V.J., et al. Pituitary abnormalities in eating disorders: further evidence from MRI studies. Prog Neuropsychopharmacol Biol Psychiatry 15 (1991) 351-356
15. Doraiswamy P.M., Potts J.M., Axelson D.A., Husain M.M., Lurie S.N., Na C., et al. MR assessment of pituitary gland morphology in healthy volunteers: age- and gender-related differences. AJNR Am J Neuroradiol 13 (1992) 1295-1299
16. Eker C., Ovali G.Y., Ozan E., Eker O.D., Kitis O., Coburn K., et al. No pituitary gland volume change in medication-free depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1628-1632
17. Elster A.D., Chen M.Y., Williams III D.W., and Key L.L. Pituitary gland: MR imaging of physiologic hypertrophy in adolescence. Radiology 174 (1990) 681-685
18. Findley D.B., Leckman J.F., Katsovich L., Lin H., Zhang H., Grantz H., et al. Development of the Yale Children's Global Stress Index (YCGSI) and its application in children and adolescents ith Tourette's syndrome and obsessive-compulsive disorder. J Am Acad Child Adolesc Psych 42 (2003) 450-457
19. First M., Spitzer R., Bibbon M., and Williams J. Structured clinical interview for DSM-IV Axis I disorder (1996), New York State Psychiatric Institute, New York
20. Friedman E., Krieger D.T., Mezey E., Leranth C., Brownstein M.J., and Palkovits M. Serotonergic innervation of the rat pituitary intermediate lobe: decrease after stalk section. Endocrinology 112 (1983) 1943-1947
21. Gehris T.L., Kathol R.G., Black D.W., and Noyes Jr. R. Urinary free cortisol levels in obsessive-compulsive disorder. Psychiatry Res 32 (1990) 151-158
22. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46 (1989) 1006-1011
23. Goudreau J.L., Lindley S.E., Lookingland K.J., and Moore K.E. Evidence that hypothalamic periventricular dopamine neurons innervate the intermediate lobe of the rat pituitary. Neuroendocrinology 56 (1992) 100-105
24. Goudreau J.L., Falls W.M., Lookingland K.J., and Moore K.E. Periventricular-hypophysial dopaminergic neurons innervate the intermediate but not the neural lobe of the rat pituitary gland. Neuroendocrinology 62 (1995) 147-154
25. Heisler L.K., Pronchuk N., Nonogaki K., Zhou L., Raber J., Tung L., et al. Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation. J Neurosci 27 (2007) 6956-6964
26. Kluge M., Schussler P., Weikel J., Dresler M., Zuber V., Querfurt F., et al. Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorder. Psychoneuroendocrinology 31 (2006) 1098-1104
27. Kluge M., Schussler P., Kunzel H.E., Dresler M., Yassouridis A., and Steiger A. Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. J Psychiatr Res 41 (2007) 928-933
28. Krishnan K.R., Doraiswamy P.M., Lurie S.N., Figiel G.S., Husain M.M., Boyko O.B., et al. Pituitary size in depression. J Clin Endocrinol Metab 72 (1991) 256-259
29. Kunwar S., and Wilson C.B. Pediatric pituitary adenomas. J Clin Endocrinol Metab 84 (1999) 4385-4389
30. Ljubic-Thibal V., Morin A., Diksic M., and Hamel E. Origin of the serotonergic innervation to the rat dorsolateral hypothalamus: retrograde transport of cholera toxin and upregulation of tryptophan hydroxylase mRNA expression following selective nerve terminals lesion. Synapse 32 (1999) 177-186
31. Lucey J.V., Butcher G., Clare A.W., and Dinan T.G. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit. Acta Psychiatr Scand 87 (1993) 384-388
32. Lurie S.N., Doraiswamy P.M., Husain M.M., Boyko O.B., Ellinwood Jr. E.H., Figiel G.S., et al. In vivo assessment of pituitary gland volume with magnetic resonance imaging: the effect of age. J Clin Endocrinol Metab 71 (1990) 505-508
33. MacMaster F.P., Russell A., Mirza Y., Keshavan M.S., Banerjee S.P., Bhandari R., et al. Pituitary volume in pediatric obsessive-compulsive disorder. Biol Psychiatry 59 (2006) 252-257
34. MacMaster F.P., Russell A., Mirza Y., Keshavan M.S., Taormina S.P., Bhandari R., et al. Pituitary volume in treatment-naive pediatric major depressive disorder. Biol Psychiatry 60 (2006) 862-866
35. MacMaster F.P., El-Sheikh R., Upadhyaya A.R., Nutche J., Rosenberg D.R., and Keshavan M. Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: a pilot study. Schizophr Res 92 (2007) 207-210
36. MacMaster F.P., Keshavan M., Mirza Y., Carrey N., Upadhyaya A.R., El-Sheikh R., et al. Development and sexual dimorphism of the pituitary gland. Life Sci 80 (2007) 940-944
37. McCracken J.T., and Hanna G.L. Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment. J Child Adolesc Psychopharmacol 15 (2005) 581-587
38. Michelson D., Altemus M., Galliven E., Hill L., Greenberg B.D., and Gold P. Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive compulsive disorder, and healthy controls. Neuropsychopharmacology 15 (1996) 207-212
39. Mikkelsen J.D., Hay-Schmidt A., and Kiss A. Serotonergic stimulation of the rat hypothalamo-pituitary-adrenal axis: interaction between 5-HT1A and 5-HT2A receptors. Ann N Y Acad Sci 1018 (2004) 65-70
40. Mondelli V., Gianotti L., Picu A., Abbate Daga G., Giordano R., Berardelli R., et al. Neuroendocrine effects of citalopram infusion in anorexia nervosa. Psychoneuroendocrinology 31 (2006) 1139-1148
41. Monteleone P., Catapano F., Del Buono G., and Maj M. Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 89 (1994) 411-415
42. Nickel T., Sonntag A., Schill J., Zobel A.W., Ackl N., Brunnauer A., et al. Clinical and neurobiological effects of tianeptine and paroxetine in major depression. J Clin Psychopharmacol 23 (2003) 155-168
43. Oberlander T.F., Grunau R., Mayes L., Riggs W., Rurak D., Papsdorf M., et al. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Hum Dev 84 (2008) 689-697
44. Pariante C.M. Pituitary volume in psychosis: the first review of the evidence. J Psychopharmacol 22 (2008) 76-81
45. Pariante C.M., Dazzan P., Danese A., Morgan K.D., Brudaglio F., Morgan C., et al. Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 30 (2005) 1923-1931
46. Sapolsky R.M., Romero L.M., and Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21 (2000) 55-89
47. Sassi R.B., Nicoletti M., Brambilla P., Harenski K., Mallinger A.G., Frank E., et al. Decreased pituitary volume in patients with bipolar disorder. Biol Psychiatry 50 (2001) 271-280
48. Schwartz P.J., Loe J.A., Bash C.N., Bove K., Turner E.H., Frank J.A., et al. Seasonality and pituitary volume. Psychiatry Res 74 (1997) 151-157
49. Suzuki M., Takashima T., Kadoya M., Konishi H., Kameyama T., Yoshikawa J., et al. Height of normal pituitary gland on MR imaging: age and sex differentiation. J Comput Assist Tomogr 14 (1990) 36-39
50. Tandon R., and Halbreich U. The second-generation 'atypical' antipsychotics: similar improved efficacy but different neuroendocrine side effects. Psychoneuroendocrinology 28 Suppl 1 (2003) 1-7
51. Tandon R., Mazzara C., DeQuardo J., Craig K.A., Meador-Woodruff J.H., Goldman R., et al. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome. Biol Psychiatry 29 (1991) 953-964
52. Weizman R., Gil-Ad I., Hermesh H., Munitz H., and Laron Z. Immunoreactive beta-endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorder. Clin Neuropharmacol 13 (1990) 297-302
53. Wilson J.D., Foster J.W., Kronenberg H.M., and Larsen P.R. Williams textbook of endocrinology. 9th ed. (1998), W. B. Saunders, Philadelphia
54. Zohar J., Insel T.R., and Rasmussen S. The psychobiology of obsessive-compulsive disorder (1991), Springer, New York